Skip to main content
. Author manuscript; available in PMC: 2015 Jan 11.
Published in final edited form as: J Carcinog Mutagen. 2013 Aug 5;Suppl 7:4. doi: 10.4172/2157-2518.S7-004

Table 1.

NF-κB, p53, miR-21 and miR-34ac targeted gene programs of HNSCC tissues.

Cancer location Genes in the network
Hypopharyngeal ALOX12B, CCL4, CD48, IGFBP3, IRF4, LAMB3, LDHA, PCBP1, S100A2, SFN, SPP1, TMEM109
Oral cavity ARHGAP1, ASS1, BCL2, BHMT, BMP4, CEP57, COL1A2, CPEB3, CR2, CSF1, CXCR5, DNAJC16, FAS, GNLY, GPR64, GZMB, HNRNPK, IER3, IFNB1, MMP9, NFKB2, NOD2, PERP, PLA2G4A, PLAU, PSMA2, SEMA4C, SERPINE1, SERPINF1, STAT4, TGFBI, TNC
Both locations ALDOA, IL1B, IL6, IL8, MMP1, PTX3, SELE, TP63, TPM1,

The target genes of transcription factors and miRNAs were predicted using the matrix decomposition-based method, based on microarray datasets of hypopharyngeal [124] and oral [125] metastatic vs. non-metastatic tumor tissues. Genes are presented as uniquely identified in hypopharyngeal cancer or oral cancer, or as appearing in both locations. Genes in bold are consistent with those genes differentially expressed and predicted to be under the regulation of NF-κB and TP53 in HNSCC cell lines with different TP53 mutation status [18,19].